Medicare negotiation
Most Read
Biden abandons his push to lower drug prices
The four senators who could make or break Democrats’ drug pricing ambitions
Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs
Key Senate committee considers a carveout for small biotech companies in drug pricing reforms
Three years after the Senate grilled drugmakers … nothing’s changed
Insulin giants Eli Lilly and Novo Nordisk boosted their lobbying spending as Democrats eyed pricing reform
What does the Build Back Better Act actually mean for the health care industry?
All Coverage
advertisement
